Regeneron (REGN) Announces IDMC Finds Clear Efficacy for REGEN-COV in Phase 3 COVID-19 Outpatient Outcomes Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. TSLA
7. AMD
8. META
9. AMC
10. COHR

Go back to Regeneron (REGN) Announces IDMC Finds Clear Efficacy for REGEN-COV in Phase 3 COVID-19 Outpatient Outcomes Trial
Regeneron (NASDAQ: REGN) Delayed: 798.17 +13.32 (1.70%)
Previous Close $784.85    52 Week High $592.36 
Open $786.03    52 Week Low $325.35 
Day High $801.44    P/E 209.49 
Day Low $779.96    EPS $3.81 
Volume 704,412